Mad River Investors Decreases Stock Position in CME Group Inc. (NASDAQ:CME)

Mad River Investors trimmed its position in shares of CME Group Inc. (NASDAQ:CME) by 74.3% in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,318 shares of the financial services provider’s stock after selling 3,811 shares during the quarter. CME Group makes up approximately 0.2% of Mad River Investors’ investment portfolio, making the stock its 23rd largest position. Mad River Investors’ holdings in CME Group were worth $291,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. CVA Family Office LLC boosted its holdings in shares of CME Group by 11.8% during the 3rd quarter. CVA Family Office LLC now owns 436 shares of the financial services provider’s stock worth $96,000 after purchasing an additional 46 shares during the last quarter. Capital Advisors Ltd. LLC boosted its stake in CME Group by 4.3% during the first quarter. Capital Advisors Ltd. LLC now owns 1,160 shares of the financial services provider’s stock worth $250,000 after buying an additional 48 shares during the last quarter. Lester Murray Antman dba SimplyRich grew its holdings in CME Group by 0.7% in the 2nd quarter. Lester Murray Antman dba SimplyRich now owns 7,667 shares of the financial services provider’s stock valued at $1,507,000 after buying an additional 50 shares in the last quarter. Essex LLC increased its stake in shares of CME Group by 3.3% in the 1st quarter. Essex LLC now owns 1,649 shares of the financial services provider’s stock worth $355,000 after acquiring an additional 52 shares during the last quarter. Finally, Quent Capital LLC raised its holdings in shares of CME Group by 10.2% during the 3rd quarter. Quent Capital LLC now owns 593 shares of the financial services provider’s stock worth $131,000 after acquiring an additional 55 shares during the period. 87.75% of the stock is owned by institutional investors and hedge funds.

CME Group Stock Down 1.3 %

CME Group stock traded down $2.96 during mid-day trading on Wednesday, hitting $223.21. The company had a trading volume of 734,975 shares, compared to its average volume of 1,932,018. The stock has a market cap of $80.37 billion, a price-to-earnings ratio of 25.73, a PEG ratio of 7.76 and a beta of 0.55. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.10. CME Group Inc. has a 1 year low of $190.70 and a 1 year high of $230.12. The business has a fifty day moving average of $217.70 and a 200 day moving average of $208.53.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.53 by $0.03. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The company had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.53 billion. During the same quarter last year, the company posted $2.30 earnings per share. The business’s quarterly revenue was up 12.7% compared to the same quarter last year. On average, sell-side analysts expect that CME Group Inc. will post 10.04 earnings per share for the current fiscal year.

CME Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, September 25th. Investors of record on Monday, September 9th were paid a dividend of $1.15 per share. This represents a $4.60 dividend on an annualized basis and a yield of 2.06%. The ex-dividend date was Monday, September 9th. CME Group’s dividend payout ratio is currently 52.33%.

Insiders Place Their Bets

In other CME Group news, CFO Lynne Fitzpatrick sold 754 shares of the company’s stock in a transaction that occurred on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total transaction of $163,610.46. Following the completion of the sale, the chief financial officer now directly owns 13,261 shares of the company’s stock, valued at $2,877,504.39. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other CME Group news, CFO Lynne Fitzpatrick sold 754 shares of the company’s stock in a transaction on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total transaction of $163,610.46. Following the completion of the transaction, the chief financial officer now owns 13,261 shares in the company, valued at approximately $2,877,504.39. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Bryan T. Durkin sold 7,593 shares of CME Group stock in a transaction dated Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the sale, the director now directly owns 55,607 shares in the company, valued at approximately $11,932,706.13. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. 0.30% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on CME. TD Cowen began coverage on shares of CME Group in a report on Thursday, September 26th. They set a “hold” rating and a $221.00 price target for the company. Piper Sandler lifted their target price on CME Group from $225.00 to $240.00 and gave the company an “overweight” rating in a research report on Tuesday, October 8th. Keefe, Bruyette & Woods upped their price target on CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a research note on Thursday, July 25th. Redburn Atlantic downgraded CME Group from a “buy” rating to a “neutral” rating and set a $244.00 price objective for the company. in a research report on Tuesday, October 8th. Finally, Royal Bank of Canada restated a “sector perform” rating and issued a $235.00 price objective on shares of CME Group in a report on Thursday, October 3rd. Four investment analysts have rated the stock with a sell rating, seven have given a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat.com, CME Group has an average rating of “Hold” and an average price target of $220.07.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.